BR + Idelalisib in RR. Data from ASCO and ASH ... - CLL Support

CLL Support

22,985 members39,471 posts

BR + Idelalisib in RR. Data from ASCO and ASH 2015

Justasheet1 profile image
1 Reply

cllsociety.org/2015/05/asco...

Thanks to Dr Koffman at CLL Society for this bit of good news. Pretty durable response for such a tough crowd.

Jeff

Written by
Justasheet1 profile image
Justasheet1
To view profiles and participate in discussions please or .
Read more about...
1 Reply
AussieNeil profile image
AussieNeilPartnerAdministrator

Now updated for ASH:

ash.confex.com/ash/2015/web...

Check out the Kaplan Meyer curve (Fig 1) for the progression free survival comparison!

Neil

Not what you're looking for?

You may also like...

My Take on 3 Interesting Papers on CLL from ASCO 2015

Friends, This week on CLL Society (http://cllsociety.org) in our 2015 conference coverage...

Reporting from ASCO 2019 (yes ASCO, not ASH)

Hi, With ASH looming, it’s about time I finish up my reporting from ASCO 2019, the other huge...

ASH 2015: Dr. John M Pagel on the Problems with Idelalisib as Frontline Therapy in CLL

It has been a while since I posted an interview on my blog first instead of the CLL Society...

Part 2 of ASH Interview with Dr. Sharman, a patient meeting in Seattle and off to iwCLL later tonight

Friends, This week on the CLL Society website, in our Conference coverage section, we share the...

CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCO

Hi, Just back from a frenetic and fantastic ASH, but still have news to share from ASCO. But first...